Abstract
This Frost & Sullivan research service titled European Haematology Diagnostics
Market provides a complete analysis of key drivers, restraints and trends in
the market. It also offers vendors strategic solutions to enable them to gain
a competitive advantage in this growing market. Within the scope of this
research service, haematology diagnostics is defined as revenues generated
through diagnostic assays and services, which are performed primarily in a
laboratory and in intensive care units and outpatient wards with the help of a
POC instrument. The research service also provides an in-depth examination of
haematology diagnostics options that are available with respect to laboratory
testing and POC testing.
This analysis is available through our Drug Discovery Technologies Growth
Partnership Services programme. With this programme, clients receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Councils.
View Cart
